MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2027

Conditions

Non-small Cell Lung Cancer

Interventions

PROCEDURE

Operable

Enrolled patients capable of surgical treatment

Trial Locations (1)

RECRUITING

Jiangsu Cancer Institute & Hospital, Nanjing

All Listed Sponsors

lead

Jiangsu Cancer Institute & Hospital

OTHER